Prevalence of BRCA1 and BRCA2 mutations in Japanese patients with triple‑negative breast cancer: A single institute retrospective study-Reference-Cited by-同舟云学术

Prevalence of BRCA1 and BRCA2 mutations in Japanese patients with triple‑negative breast cancer: A single institute retrospective study

Published:2021-03-12 Issue:5 Volume:14 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Fujisawa Fumie¹,Tamaki Yasuhiro²,Inoue Tazuko²,Nakayama Takahiro³,Yagi Toshinari¹,Kittaka Nobuyoshi³,Yoshinami Tetsuhiro¹,Nishio Minako¹,Matsui Saki³,Kusama Hiroki³,Kamiura Shoji⁴

Affiliation:

1. Department of Medical Oncology, Osaka International Cancer Institute, Chuo‑ku, Osaka 541‑8567, Japan

2. Division of Familial Cancer Clinic, Department of Genetic Medicine, Osaka International Cancer Institute, Chuo‑ku, Osaka 541‑8567, Japan

3. Breast and Endocrine Surgery, Osaka International Cancer Institute, Chuo‑ku, Osaka 541‑8567, Japan

4. Department of Gynecology, Osaka International Cancer Institute, Chuo‑ku, Osaka 541‑8567, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and Cancer;Cells;2024-08-23

2. Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer;BMC Cancer;2024-08-12

3. A global perspective on the ethnic-specific BRCA variation and its implication in clinical application;Journal of the National Cancer Center;2023-03

4. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine;Breast Cancer Research and Treatment;2022-08-05

5. Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer;Evidence-Based Complementary and Alternative Medicine;2022-04-13